Bfsg LLC Lowers Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bfsg LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 72.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,984 shares of the healthcare conglomerate's stock after selling 5,192 shares during the quarter. Bfsg LLC's holdings in UnitedHealth Group were worth $1,039,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently made changes to their positions in the company. Capital & Planning LLC lifted its position in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after purchasing an additional 79 shares during the last quarter. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new position in UnitedHealth Group in the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Finally, Bank Pictet & Cie Europe AG boosted its holdings in shares of UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after purchasing an additional 9,872 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction on Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 0.5%

NYSE:UNH opened at $309.14 on Wednesday. The firm has a 50-day simple moving average of $376.32 and a two-hundred day simple moving average of $469.08. The firm has a market cap of $280.43 billion, a P/E ratio of 12.95, a P/E/G ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the business posted $6.91 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. UnitedHealth Group's payout ratio is presently 37.02%.

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.